Tandem Diabetes Care Inc (TNDM)

Financial leverage ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Total assets US$ in thousands 967,658 957,730 937,503 941,045 952,658 939,909 946,676 954,145 1,052,780 1,047,520 1,036,580 1,015,280 905,137 850,279 795,250 754,273 716,415 672,988 616,239 343,327
Total stockholders’ equity US$ in thousands 263,098 237,710 233,875 243,064 313,632 314,000 329,234 338,753 439,947 421,822 449,584 437,382 433,112 389,654 346,085 313,414 366,305 326,544 267,704 207,176
Financial leverage ratio 3.68 4.03 4.01 3.87 3.04 2.99 2.88 2.82 2.39 2.48 2.31 2.32 2.09 2.18 2.30 2.41 1.96 2.06 2.30 1.66

December 31, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $967,658K ÷ $263,098K
= 3.68

The financial leverage ratio of Tandem Diabetes Care Inc has shown an increasing trend over the period from March 31, 2020, to December 31, 2024. The ratio started at 1.66 in March 2020, increased gradually to reach 4.01 by June 30, 2024. This indicates that the company's reliance on debt to finance its operations and growth has been increasing steadily. A higher financial leverage ratio suggests that the company is financing a larger portion of its assets through debt, which can increase the risk to shareholders in times of financial distress. It is important for investors and stakeholders to closely monitor this ratio to assess the company's ability to meet its financial obligations and manage its debt effectively.